(2) *GLAXO TO RETAIN EXISTING HOLDING IN VIIV HEALTHCARE

*GLAXO TO RETAIN EXISTING HOLDING IN VIIV HEALTHCARE

Alerts: HALISTER1, HALISTER Source: BN (Bloomberg News)

Tickers GSK LN (GlaxoSmithKline PLC)

To de-activate the "HALISTER1" alert, run {NLRT DEACT HALISTER1 <GO>}. To modify this alert, run {NLRT EDIT HALISTER1 <GO>}.

To de-activate the "HALISTER" alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283

HALISTER: Alexion to Pay $8.4 Billion to Buy Synageva in Rare-Disease Push

Alexion to Pay $8.4 Billion to Buy Synageva in Rare-Disease Push

Alert: HALISTER Source: BN (Bloomberg News)

Tickers ALXN US (Alexion Pharmaceuticals Inc) GEVA US (Synageva BioPharma Corp)

People David Hallal (Alexion Pharmaceuticals Inc)

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283

HALISTER: MORE: Alexion to Buy Synageva Ahead of Potential Kanuma Approval

MORE: Alexion to Buy Synageva Ahead of Potential Kanuma Approval

Alert: HALISTER Source: BFW (Bloomberg First Word)

Tickers ALXN US (Alexion Pharmaceuticals Inc) 3690784Z US (Baker Brothers Investments) BMRN US (BioMarin Pharmaceutical Inc) GEVA US (Synageva BioPharma Corp)

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283

HALISTER: *ALEXION TO BUY SYNAGEVA IN DEAL VALUED AT $8.4B NET OF CASH

*ALEXION TO BUY SYNAGEVA IN DEAL VALUED AT $8.4B NET OF CASH

Alert: HALISTER Source: BN (Bloomberg News)

Tickers ALXN US (Alexion Pharmaceuticals Inc)

People David Hallal (Alexion Pharmaceuticals Inc) Felix Baker (Baker Brothers Advisors LLC) Leonard Bell (Alexion Pharmaceuticals Inc) Sanj Patel (Synageva Biopharma Corp)

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283